Fortius F 20 Tablet is a combination medication containing Fenofibrate 160mg and Rosuvastatin 20mg, designed to manage abnormal lipid levels in patients at risk of cardiovascular diseases. Fenofibrate works by activating peroxisome proliferator-activated receptors (PPARs), which help reduce triglycerides and increase high-density lipoprotein (HDL) cholesterol, thereby improving lipid metabolism. Rosuvastatin, a potent statin, inhibits HMG-CoA reductase, an enzyme involved in cholesterol synthesis, effectively lowering low-density lipoprotein (LDL) cholesterol and total cholesterol levels. The synergistic action of these two agents provides comprehensive lipid control, making Fortius F 20 suitable for patients with mixed dyslipidemia or those who require additional lipid-lowering therapy beyond statins alone. This combination helps reduce the risk of atherosclerosis, heart attacks, and strokes. Fortius F 20 should be used under medical supervision, with regular monitoring of liver function, kidney function, and lipid profiles to ensure safety and efficacy. Patients are advised to maintain a healthy diet and lifestyle alongside medication. Common side effects may include gastrointestinal discomfort, muscle pain, or elevated liver enzymes. Promptly report any unusual symptoms to a healthcare provider. Fortius F 20 Tablet offers an effective treatment option for comprehensive lipid management in adults.